Corporate Round - Xcell Biosciences

Corporate Round - Xcell Biosciences

Investment Firm

Overview

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

Announced Date

Apr 01, 2024

Funding Type

Corporate Round

Highlights

Location

United States, North America

Social

Investor Lead

LabCorp

LabCorp

No designation

Participant Investors

1

Investor Name
Participant InvestorLabCorp

Round Details and Background

Xcell Biosciences raised an undisclosed amount on 2024-04-01 in Corporate Round

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 19, 2022
Series B - Xcell Biosciences
5-27.5M
Apr 01, 2024
Corporate Round - Xcell Biosciences
1-undefined
Feb 16, 2017
Series A - Xcell Biosciences
1-12.0M
Oct 01, 2014
Convertible Note - Xcell Biosciences
1-100.0K

Recent Activity

There is no recent news or activity for this profile.